89bio, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €755.40M +265.0% €105.59M -141.3% 14.0% +1.4 pp N/A N/A
    (estimated) €206.97M +645.2% -€255.84M -28.0% -123.6% +12 pp N/A N/A
    (estimated) €27.78M +∞% -€355.40M +8.1% -1,279.5% -13 pp N/A N/A
    (estimated) €0.00 +NaN% -€328.68M +11.0% N/A N/A N/A
    (estimated) €0.00 +NaN% -€296.15M -6.5% N/A N/A N/A
    €0.00 +NaN% -€316.64M +158.2% N/A -€317.27M +184.7% N/A
    €0.00 +NaN% -€122.65M +39.4% N/A -€111.43M +59.3% N/A
    €0.00 +NaN% -€88.01M +13.2% N/A -€69.94M +5.7% N/A
    €0.00 +NaN% -€77.74M +82.1% N/A -€66.18M +66.4% N/A
    €0.00 +NaN% -€42.70M -13.8% N/A -€39.78M +82.1% N/A
    €0.00 +NaN% -€49.53M +255.0% N/A -€21.84M +103.7% N/A
    €0.00 -€13.95M N/A -€10.72M N/A

    Notifications